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Abstract
Background: Bronchoscopic balloon dilatation (BBD) is a common strategy in the treatment of bronchostenosis.
However, the longer dilating time in each inflation cycle (approximately 3–5 min) without mechanical ventilation
is not possible for the treatment of tracheal stenosis.
Case presentation: In this study, we reported our experience of BBD with shorter dilating time (10 s or 1 min) and
intermittent ventilation for the repair of tuberculous-associated tracheal stenosis in two cases of our hospital. After the
surgeries, the physical examinations and pulmonary function were tested. In case 1, the cough and dyspnea
syndromes subsided, wheeze and strid or in lungs were remarkably reduced, tracheal lumen was considerably
expanded and pulmonary function was improved following the treatment. For the case 2, her chest tightness,
shortness of breath symptoms were alleviated after the treatment. The middle and lower trachea stenosis was
dilated and patent, but the right main bronchus stenosis was slightly improved. No restenosis occurred in the
two patients in 1 year outpatient follow-up.
Conclusions: These findings suggest that our modification in BBD is safe and effective for treating this
patient with tracheal stenosis caused by tuberculosis, but the longer-term effect of the surgery in a large
number of patients with longer follow-up remains to be seen.
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Background
Benign tracheal stenosis is a complication of various dis-
eases and interventional managements [1–3]. Tubercu-
losis (TB) and endotracheal intubation are two most
common causes of the tracheal stenosis. The symptoms
of tracheal stenosis vary according to the site of the lesion
and severity of tracheal narrowing. They usually include
shortness of breath, cough, expectoration, stridor or,
wheeze, and respiratory tract infections. If left untreated,
tracheal stenosis might even lead to suffocation or tracheal
cancer.
There are a variety of treatment options for patients
with tracheal stenosis, which include surgical resection,
balloon dilatation, stent placement, cryotherapy and
laser therapy [4, 5]. Of the options, surgical resection
and reconstruction are the best definitive treatment
against tracheal stenosis [6]. However, many patients
could not tolerate the surgery or are not suitable be-
cause of poor health condition, impaired pulmonary
functions, anatomic limitations or technical difficulties.
Stent placement is also a widely-used approach, but it
might cause various complications, such as benign air-
way restenosis as a result of stent migration and granula-
tion tissue proliferation [7].
In recent years interventional pulmonology technologies
have been substantially advanced, and bronchoscopic bal-
loon dilatation (BBD) characterized with lower morbidity
and mortality has been increasingly recognized as an
effective therapy for benign bronchus and lobe bronchus
stenosis [8, 9]. However, there are few studies specific-
ally targeting tracheal stenosis. Thus, this study aimed
to evaluate the therapeutic effects of BBD on tracheal
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stenosis caused by TB in two cases. Moreover the longer
dilating time in each inflation cycle (approximately 3–
5 min) without mechanical ventilation during bronchus
dilatation is not possible for the repair of tracheal stenosis.
In this study, we designed shorter dilating time (10 s or
1 min) and intermittent ventilation for the repair of tra-
cheal stenosis caused by TB (Additional file 1).
Case Presentation
Case 1
All persons have given their informed consent prior to
their inclusion in the study, and all human studies have
been approved by the local Ethics Committee and per-
formed in accordance with the ethical standards.
A 20-year-old woman was admitted to her local hos-
pital in June, 2010 because of cough and expectoration
for 3 months. She was diagnosed as tracheal tuberculosis
according to the positive acid-fast bacilli in her sputum
and granuloma-like lesions on the tracheal wall with case-
ous necrosis by bronchoscopy with biopsy. She was given
anti-TB medications consisting of Isoniazid (INH), Rifam-
picin (RFP), Ethambutol (EMB) and Pyrazinamide (PZA).
However, her symptoms were not relieved, but deterio-
rated after 1 month. The bronchoscopy was performed
again, revealing tracheal scar stenosis. The biopsy showed
chronic inflammation of the upper tracheal mucosa with
fibrous tissue proliferation. She was admitted to our hos-
pital on December 9, 2010 for further treatment.
On admission, physical examinations showed that she
was clear-minded, breath was 25 times per min, pulse
was 93 beats per min, and blood pressure was 126/
78 mmHg. On chest examination, her breath sound was
rough with wheeze on both sides. The result of abdominal
examination was normal. Pulmonary function testing
(PFT) showed that her pulmonary function was impaired
[vital capacity (VC) =3.29 L (91.9 % pred), the forced
expired volume in 1 s (FEV1) =1.11 L (35.2 % pred), the
ratio between FEV1 and the forced vital capacity (FEV1/
FVC) =33.65 %]. A chest computed tomography (CT;
Fig. 1) revealed tracheal stenosis at the thoracic inlet,
patchy, nodule-like and streaking lesions with uneven
density in both lobes of the lung, and normal lymph node
sat mediastinum and lung hilus.
After admission, she continued to receive anti-TB
drugs (INH, RFP, EMB and PZA), and then changed to
anti-TB drugs [INH, RFP, EMB and streptomycin(SM)]
due to liver injury. Electronic bronchoscopy was per-
formed at 3 days after admission (December, 13) under
general anesthesia. Mechanical ventilation was used to
assist her breathing. The bronchoscopy showed a ring-
like scar stenosis about 2 cm below the normal glottis.
The bronchoscope (BF BC-260, Olympus Corporation,
Tokyo, Japan) with an external diameter of4.9 mmcould
pass through the stenosis, but not the bronchoscope
(BF IT-260, Olympus Corporation, Tokyo, Japan) with the
outer diameter of 5.9 mm. The bronchoscopy (BF BC-
260) revealed that the airway wall was rough, the
narrowed airway was about 5 cm in length, and the lower
end of the stenosis was about 5 cm away from the sharp
tracheal carina. No abnormality in the bilateral lobar
bronchus was observed.
The tracheal stenosis was treated using the MK58880bal-
loon (1 cm in diameter, Boston Scientific Cork Company,
Ireland) with the pressure increased to 303.9 Kpa (3 atm)
to dilate the trachea for 10s during which the mechanical
ventilation was stopped. Subsequently, the pressure started
to decrease and the mechanical ventilation was recovered.
The balloon dilatation was repeated 3 times. The bronchial
lumen expanded only slightly following the procedure
(Fig. 2a, b). On the second day of the balloon dilatation, her
symptoms including coughing, shortness of breath, were
alleviated. The wheeze and stridor of lungs were reduced
under physical examination.
Ten days later, she received bronchoscopic re-
examination of the airways and the results still indicated
that the bronchoscope (BF BC-260, Olympus Corporation,
Tokyo, Japan) could pass through the stenosis, but not the
bronchoscope (BF IT-260, Olympus Corporation, Tokyo,
Japan). Thus, the high-pressure balloon dilatation treat-
ment was performed again during which the pressure of
the balloon was increased to 5 atm and then main-
tained for 10 s. After 8 inflation cycles, the broncho-
scope (BF IT-260, Olympus Corporation, Tokyo, Japan)
can pass through the stenosis. However, her cough and
shortness of breath symptoms were deteriorated follow-
ing the treatment, which may be caused by the pres-
ence of bronchial edema and spasm. These symptoms
were resolved by intravenous and intranasal administra-
tion of dexamethasone using atomization device. On
the third day after treatment, her cough and shortness
Fig. 1 A chest computed tomography scan showing tracheal
stenosis at thoracic inlet before treatment in Case 1
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of breath symptoms were apparently ameliorated. The
physical examinations showed that wheeze and stridor of
lungs were remarkably reduced. Then, she was discharged.
Fifty days after the treatment, a repeat PFT showed that
her pulmonary function was remarkably improved (VC =
3.40 L (94.8 % pred), FEV1 = 2.06 L (65.5 % pred), FEV1/
FVC= 60.51 %). A repeat bronchoscopy showed that the
ring-like scar stenosis was dilated, allowing the passage of
bronchoscopy (BF IT-260, Olympus Corporation, Tokyo,
Japan) (Fig. 2c). During her 1 year outpatient follow-up,
no tracheal stenosis was observed. Timeline of past history
of the patient was listed in Table 1.
Case 2
A 39-year-old female patient was admitted to our hospital
on October 13, 2010 because of cough and expectoration
for 3 years, chest tightness and shortness of breath for ap-
proximately 1 month. On November, 2007, she was ever
admitted to a local hospital with complaints of cough, ex-
pectoration and white phlegm, but not fatigue, night
sweats, fever and chest pain. The local hospital diagnosis
was bronchial asthma. She was given anti-inflammatory
drugs, but her symptoms persisted.
On admission, physical examinations revealed that she
was clear-minded, breath was 26 times per min, pulse was
100 beats per min, and blood pressure was 132/80 mmHg.
Chest examination revealed wheeze in the trachea, and
rough breath sound with in aspiratory and expiratory
wheeze in both lungs. Her abdominal examination was
normal. No pathological syndrome was observed. Chest
CT scan revealed pulmonary TB on both sides, especially
in the middle and lower lobe. Lower tracheal stenosis,
right bronchus stenosis and right pleural thickening were
also observed (Fig. 3). Sputum smear for acid-fast bacilli
was positive. Subsequently she was given combined anti-
TB treatment (INH, RFP, EMB and PZA) since December
13, 2010. On December 17, 2010, bronchoscopy was per-
formed under local anesthesia, revealing that as shown in
Fig. 4a, the glottis was normal, false diverticula was
present in the middle segment of trachea, and stenosis
was present in the middle and lower trachea, barely
allowing the passage of the bronchoscopy (BF BC-260,
Olympus Corporation, Tokyo, Japan). Tracheal mucosal
congestion and swelling were present, and the left main
bronchus and lobar bronchus on the left side was pa-
tent, although with the presence of viscous secretions.
However, the right main bronchial stenosis was ob-
served with caseous necrotic material attached to the
bronchial orifice and could not permit the passage of
the bronchoscopy (BF BC-260, Olympus Corporation,
Tokyo, Japan). Our final diagnosis was active secondary
pulmonary tuberculosis, tracheal and right main bron-
chial tuberculosis. On January 12, 2011, the patient was
administrated with endotracheal intubation. After a
month, the endotracheal catheter was removed and
then, the patient was discharged.
On February18, 2011, she was re-admitted to our hos-
pital. The bronchoscopic high-pressure (6 atm) balloon
dilatation (MK58880, Boston Scientific Cork Company,
Ireland) was performed in the middle and lower trachea for
the patient under general anesthesia and electrocardiogram
Fig. 2 Photographs showing bronchus stenosis before and after treatment in Case 1. a Photographs showing bronchus lumen before treatment;
b Photographs showing bronchus lumen immediately after treatment; c Photographs showing bronchus lumen 50 days after treatment
Table 1 Timeline of case 1
Time Important event
Dec 9, 2010 Admission
Dec 13, 2010 First balloon dilation treatment
Dec 23, 2010 Second balloon dilation treatment
Feb 12, 2011 Pulmonary function check-ups
Fig. 3 A chest computed tomography scan showing tracheal
stenosis and right bronchial stenosis of the patient in Case 2
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(ECG) monitoring. Mechanical ventilation was applied to
assist the patient’s breathing. When the oxygen saturation
was below 95 %, the balloon stopped dilatation and started
empting. The balloon dilatation lasted as long as 1.5 min
for each cycle. When the oxygen saturation recovered to be
above 99 %, the second balloon dilatation was performed
and repeated. The bronchoscopic high-pressure (5 atm)
balloon dilatation was also performed under ECG moni-
toring for the right main bronchial stenosis twice
with5 min for each cycle. After the balloon dilatation,
the BC-260bronchoscope could pass through the
middle and lower trachea stenosis but not the IT-
260bronchoscope. For the right main bronchus stenosis,
BC-260 bronchoscope could not even pass (Fig. 4b). Her
chest tightness, shortness of breath symptoms were im-
proved after the balloon dilatation treatment, but still
could not tolerate PFT.
She received balloon dilatation treatment for 5 more
times on March 28, April 22, May 6, June 7 and July 18,
2011, respectively. On June 28, 2012, a repeat bronchos-
copy showed that the middle and lower trachea stenosis
was dilated and patent without the presence of conges-
tion and swelling, allowing the passage of the IT-260
bronchoscope. The orifice of the right main bronchus
was still narrowed, could not permit the passage of the
bronchoscopy (BC-260), but the caseous necrotic mate-
rials disappeared (Fig. 4c). No restenosis occurred in the
patient in 1 year outpatient follow-up. Timeline of case
2 was listed in Table 2.
Literature review
We searched the WANFANG and PubMed database for
articles published between 1984 and 2014 in the Chinese-
and English-language literature. There were several stud-
ies on the application of balloon dilatation in management
of combination of main bronchus and lobe bronchus
stenosis, yet rare reports on specific treatment of TB-
associated tracheal stenosis by BBD were retrieved.
The search of PubMed database yielded 13 articles. A
total of 474 patients were involved in the retrieved
articles from PubMed database and the present study.
The total information retrieved was summarized in Table 3
[8–20]. Of the 474 patients, the tracheal stenosis of 4
infant patients results from endotracheal intubation
[10]. The etiologies of the 474 patients include bron-
chial carcinoma, other malignancy, lung carcinoma
post-tracheal resection, endotracheal intubation, tra-
cheal tuberculosis, prolonged mechanical ventilation,
lung transplantation, Wegener’s granulomatosis, idio-
pathic stenosis, post-tracheostomy, sarcoidosis and
amyloidosis.
Discussion
BBD has become a preferred option in the management
of tracheal and bronchial stenosis. The study assessed the
effect of high pressure BBD in two patients with TB—as-
sociated tracheal stenosis. The tracheal lumen was dilated
and pulmonary function was improved following the
treatment.
There are usually two ventilation modes used in bal-
loon dilatation treatment: intermittent ventilation and
catheter ventilation. The catheter ventilation refers to
inserting the ventilator-linked catheter into trachea,
which permits easy breathing of the patients undergoing
balloon dilatation treatment. However, it carries a variety
of complications such as ventilator-associated pneumo-
nia, pneumothorax and alveolar damage. With regard to
intermittent ventilation, ventilation is stopped for the
patient when the balloon is dilated, and the ventilation is
Fig. 4 Photographs showing tracheal and bronchus stenosis in Case 2. a Photographs showing the middle and lower tracheal stenosis, and right
main bronchus stenosis with caseous necrotic material attached to the nozzle exit before the treatment; b Photographs showing the narrowed
trachea and right main bronchus immediately after the first treatment; c Photographs showing the middle and lower tracheal, and right main
bronchus after the fifth treatment
Table 2 Timeline of case 2
Time Important event
Oct 13th, 2010 Admission
Dec 17, 2010 Bronchoscopy examination
Feb 18, 2011 First balloon dilation treatment
Mar 28, 2011 Second balloon dilation treatment
Apr 22, 2011 Third balloon dilation treatment
May 6, 2011 Fourth balloon dilation treatment
Jun 7, 2011 Fifth balloon dilation treatment
Jul 18, 2011 Sixth Pulmonary function check-ups
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recovered at intermission between balloon dilatations,
thus reducing the risk of the complications. In the
present study, intermittent ventilation was applied to the
2 cases.
In most cases, single balloon dilatation for bronchus
stenosis usually lasts 3–5 min. The longest balloon dilata-
tion duration is 40 min [9]. The longer dilating time in
each inflation cycle without mechanical ventilation during
bronchus dilatation is not possible for the treatment of
tracheal stenosis. Thus, we introduced the shorter dilating
time for treatment of case 1 (10 s) and case 2 (1.5 min) in
reference to the recent studies of Shitrit et al. [8] and Low
et al. [20].
In the 474 cases retrieved, balloon pressure varies
according to the site and the type of the stenosis. The
pressure for two infant patients is 4 atm. Notably, 16 atm
is used in two cases, but induces tracheal wall laceration
[14], indicating high pressure might be dangerous. How-
ever, a novel high-handed BBD method (14 atm) is used
for a female patient with right middle segmental bronch-
ostenosis. The procedure lasts for 40 min. After the
procedure, her intermediate bronchus is observed again,
the right lower and middle lobes are reopened [9].
Symptoms, lung functions and lumen diameter are pri-
mary indicators of the efficacy of the BBD treatment.
However, tracheal stenosis is in uneven and irregular
form, and measurement of stenosis diameter is usually
based on researchers’ observation and captured images
of tracheal stenosis. Therefore, the measurement result
of stenosis diameter is inaccurate and unconvincing. In
the present study, whether the same type of broncho-
scope could pass through the narrowed lumen after the
treatment was regarded as a direct indicator of the treat-
ment outcome. Because the tracheal lumen usually
recoils after the BBD procedure, long-term assessment
for the effect of the treatment is considered more im-
portant than immediate assessment after the procedure.
In a recent study, the effect of balloon dilatation on a
female patient with bronchial TB-associated bronchoste-
nosis is assessed following 13 months of anti-bronchial
TB treatment. Dilatation of the bronchostenosis is
observed, and no complication occurs in the patient [9].
In consistence with the finding, the effect of BBD was
assessed for two cases in 1 year outpatient follow-up
after the treatment in the present study.
Although patients often show immediate satisfactory
result following BBD treatment, the effect fails to last
long. Long term follow-up reveals that additional treat-
ments, such as laser treatment and stent therapies are
required by most patients after the BBD treatment [8]. It
has been reported that syndromes of 21 consecutive
patients with broncheal stenosis are immediately relieved
following bronchoscopic interventions. However, out of
the 21 patients, only 11 remain asymptomatic at the end
of 25 months follow-up [20]. Besides, repeat sessions of
bronchoscopic interventions are required by patients
[20]. These studies unveil that bronchoscopic interven-
tions are palliative measures in the management of
airway stenosis.
Primary complications of the balloon dilatation treatment
usually include pneumothorax, mediastinal emphysema,
tracheal and broncheal wall laceration, and hemoptysis.
Table 3 Summary of clinical characteristics of the patients in
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Broncheal wall laceration occurs in two cases, due to the
exceedingly high pressure (up to 16 atm) [14]. Therefore,
the pressure of balloon inflation should be in tight control
during the procedure. On the same day of the BBD treat-
ment, the two patients presented with symptoms of cough
and dyspnea in the current study. The symptoms were de-
teriorated when the balloon was dilated, and then relieved
by subsequent intravenous administration and atomizing
inhalation of dexamethasone. One possible explanation for
the symptoms was the presence of local congestive edema
and airway spasm caused by the high pressure balloon dila-
tation. The congestion and edema would be exacerbated by
the increased pressure. In order to prevent these complica-
tions, necessary preparations must be made prior to and
post-surgery. Once the symptoms are present, immediate
measures should be taken to alleviate the syndromes in
patients. Despite these complications, the surgery is consid-
ered safe since it is performed under strict monitoring.
Furthermore, considerable efforts have been made to
improve the effect of BBD and to avoid severe complica-
tions. For instance, multi-modality treatment consisting
of electrocautery, balloon bronchoplasty, and subsequent
topical application of mitomycin-C has been used to
treat a patient with benign tracheobronchial stenosis.
The stenosis is dilated, no re-stenosis or complication is
observed following the treatment [19]. Electrocautery is
used to cut open the fibrotic stricture prior to balloon
dilatation, thus high pressure is not necessary to dilate
the balloon. Consequently, the complications caused by
excessive high pressure could be avoided. Moreover,
flexible bronchoscopy therapeutic modalities consisting
of balloon dilatation, laser resection, high-dose rate
(HDR) endobronchial brachytherapy and self-expanding
metal stent placement have used in elderly patients with
granulation tissue formation because of refractory stent.
The HDR endobronchial brachy-therapy is widely-used to
overcome mechanical obstruction of major airways, and
could prevent and treat stent-related granulation tissue
formation. The success rate of the flexible bronchoscope-
based morbidities is up to 87 % [17]. Furthermore, BBD
has been proved to be safe and effective in the manage-
ment of bronchial stenosis following lung transplantation.
It facilitates easy stent placement and reduces the use of
stent placement in patients, thus decreasing the complica-
tions induced by stent placement [18].
Conclusions
The bronchoscopic high-pressure balloon dilatation was a
safe and operable method for treating patients with tra-
cheal stenosis caused by TB. There were only two cases
described in the study. The longer-term effect of the
surgery in a large number of patients with longer follow-
up remained to be seen.
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